OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Internal Medicine is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Electrocardiographic changes associated with hypothermia	289
Non-pharmacological home remedies used by primary care patients	257
Effects of the implementation of the dynamic silver code in the emergency department	202
The role of age in recognizing cognitive impairment in the emergency department	180
A man with brown macules on the limbs	177
Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA	137
Impact of thoracoabdominal imaging on diagnosis and management in patients with suspected infective endocarditis	96
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)	94
Concerns regarding result analysis and the corresponding risk of pulmonary embolism severity and in-hospital mortality	91
How the theory of centralized aerobic-anaerobic energy balance compensation explains sudden cardiac death in young athletes	87
Effects of statins on clinical outcomes in hospitalized patients with COVID-19	83
Heart failure: An autopsy case	82
Natural history of ‘silent’ atrial fibrillation from subclinical to asymptomatic: State of the art and need for research	67
The peculiarities of COVID-19 in older people: Considerations after two years	66
A woman with purple-brown skin lesions after immunosuppressive therapy	61
Health differences between adults with and without intellectual disabilities at the internal medicine department: A first step to improve awareness of intellectual disabilities among healthcare profes	59
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation	52
Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines	50
Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus	49
Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?	48
Reconsidering the Edelman equation: impact of plasma sodium concentration, edema and body weight	47
Refining metabolic health assessment in inflammatory bowel disease risk prediction	46
Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients	46
Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease	45
A hidden cause of sudden epigastric pain in a middle-aged man	44

Telemedicine in internal medicine: A statement by the European Federation of Internal Medicine.	43
Recurrent vomiting	43
Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)	42
Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients	42
Prognostic impact of hypertension grading	41
Bridging the gap: Phenotype-specific considerations for rituximab therapy in IgG4-related disease	40
To dilate or not to dilate: the puzzle of phenotyping heart failure with mildly reduced ejection fraction	40
Aspirin and P2Y12 inhibitors in treating COVID-19	40
Different impact of chronic kidney disease in older patients with heart failure according to frailty	37
Potential mechanisms of vaccine-induced thrombosis	37
Antibiotic use in hospitalized older adults according to WHO AWaRe classification: data from the REPOSI register	37
Oral semaglutide in HFpEF: Real-world evidence and causal considerations	36
No evidence of a “July Effect” on mortality	36